Spruce Biosciences Inc logo

Spruce Biosciences Inc

NAS:SPRB (USA)   Ordinary Shares
$ 0.40 +0.018 (+4.77%) 11:09 PM EST
At Loss
P/B:
0.32
Market Cap:
$ 16.34M
Enterprise V:
$ -40.49M
Volume:
323.53K
Avg Vol (2M):
611.32K
Trade In:
Volume:
323.53K
At Loss
Avg Vol (2M):
611.32K

Business Description

Spruce Biosciences Inc logo
Spruce Biosciences Inc
NAICS : 541714 SIC : 2833
ISIN : US85209E1091

Share Class Description:

SPRB: Ordinary Shares
Description
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Name Current Vs Industry Vs History
Cash-To-Debt 18.59
Equity-to-Asset 0.79
Debt-to-Equity 0.06
Debt-to-EBITDA -0.08
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.07
Distress
Grey
Safe
Beneish M-Score -1.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.72
9-Day RSI 38.15
14-Day RSI 38.01
6-1 Month Momentum % -10.52
12-1 Month Momentum % -77.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.36
Quick Ratio 5.36
Cash Ratio 5.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.8
Shareholder Yield % 10.97

Financials (Next Earnings Date:2025-03-13 Est.)

SPRB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SPRB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Spruce Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.101
EPS (TTM) ($) -0.94
Beta 2.64
Volatility % 154.97
14-Day RSI 38.01
14-Day ATR ($) 0.037734
20-Day SMA ($) 0.46148
12-1 Month Momentum % -77.83
52-Week Range ($) 0.365 - 5.95
Shares Outstanding (Mil) 41.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Spruce Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Spruce Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Spruce Biosciences Inc Frequently Asked Questions

What is Spruce Biosciences Inc(SPRB)'s stock price today?
The current price of SPRB is $0.40. The 52 week high of SPRB is $5.95 and 52 week low is $0.37.
When is next earnings date of Spruce Biosciences Inc(SPRB)?
The next earnings date of Spruce Biosciences Inc(SPRB) is 2025-03-13 Est..
Does Spruce Biosciences Inc(SPRB) pay dividends? If so, how much?
Spruce Biosciences Inc(SPRB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1